# Third Age Health Services Limited (TAH.NZ)
## Deep Dive Analysis & DCF Valuation

---

## Company Overview

**Third Age Health Services Limited** is New Zealand's leading provider of managed medical services for aged residential care (ARC) facilities. Founded in 2010 by Bevan Walsh and listed on the NZX in February 2021, the company has grown to serve 87 aged care facilities and over 25,800 patients.

### Business Segments

1. **Aged Medical Residential Care Services** (~80% of revenue)
   - 24/7 medical care for aged care facilities
   - Rostered rounds by GPs/Nurse Practitioners
   - After-hours on-call services
   
2. **General Practice Medical Services** (~20% of revenue)
   - Community primary care clinics
   - Expanded through acquisitions (EastMed, Hub Aged Care)

### Investment Thesis

| Strength | Detail |
|----------|--------|
| **Aging Population Tailwind** | NZ's 65+ population reaching 20% by 2028; 15,000 additional beds needed by 2030 |
| **Asset-Light Model** | Minimal CapEx (<0.5% of revenue), strong FCF conversion (>100%) |
| **Recurring Revenue** | Contracted services with ARC facilities, government-funded |
| **High Returns** | ROE ~72%, ROIC ~27% |
| **Acquisition Track Record** | Disciplined M&A at reasonable multiples |

---

## Financial Summary

### Historical Performance (NZD Millions)

| Metric | FY2023 | FY2024 | FY2025 | H1 FY2026 |
|--------|--------|--------|--------|-----------|
| Revenue | 11.5 | 15.2 | 19.1 | 10.7 |
| Growth % | 21% | 32% | 26% | 45% |
| EBITDA | 2.3 | 3.2 | 4.7 | 2.8 |
| EBITDA Margin | 20% | 21% | 25% | 26% |
| Net Income | 1.1 | 1.4 | 2.3 | 1.3 |
| Free Cash Flow | 2.0 | 2.9 | 3.4 | 2.0 |

### Current Valuation Metrics

| Metric | Value |
|--------|-------|
| Share Price | NZ$4.80 |
| Market Cap | NZ$47.8M |
| Enterprise Value | NZ$49.9M |
| EV/EBITDA (TTM) | 10.7x |
| P/E (TTM) | 20.5x |
| EV/FCF | 14.3x |
| FCF Yield | 7.3% |
| Dividend Yield | 3.1% |

---

## DCF Valuation Summary

### Key Assumptions

| Input | Value | Rationale |
|-------|-------|-----------|
| **Revenue Growth** | 30% → 10% | Strong H1 momentum, moderating to sustainable growth |
| **Terminal Growth** | 2.5% | NZ GDP + population growth |
| **EBITDA Margin** | 25% → 27% | Operating leverage, scale benefits |
| **WACC** | 11.2% | Based on NZ 10Y yield (4.5%), ERP (5.5%), levered beta |
| **Tax Rate** | 28% | NZ corporate rate |

### WACC Calculation

- Risk-Free Rate: 4.5% (NZ 10-year government bond)
- Equity Risk Premium: 5.5%
- Unlevered Beta: 0.80 (healthcare services)
- Levered Beta: 1.03
- Cost of Equity: 12.2% (including 2% small-cap premium)
- After-Tax Cost of Debt: 5.0%
- **WACC: 11.2%**

### DCF Results

| Component | Value (NZ$M) |
|-----------|--------------|
| PV of Forecast FCFs | 16.8 |
| PV of Terminal Value | 51.4 |
| Enterprise Value | 68.2 |
| Less: Net Debt | (2.1) |
| **Equity Value** | **66.1** |
| Shares Outstanding | 9.95M |
| **Implied Share Price** | **NZ$6.64** |

### Upside/Downside

| Scenario | Share Price | vs Current |
|----------|-------------|------------|
| Bear Case | NZ$4.50 | -6% |
| Base Case | NZ$6.64 | +38% |
| Bull Case | NZ$9.50 | +98% |

---

## Sensitivity Analysis

### WACC vs Terminal Growth Rate

|  | 1.5% | 2.0% | **2.5%** | 3.0% | 3.5% |
|--|------|------|------|------|------|
| **9%** | 7.82 | 8.45 | 9.22 | 10.18 | 11.42 |
| **10%** | 6.54 | 6.98 | 7.52 | 8.17 | 8.97 |
| **11%** | 5.60 | 5.92 | **6.30** | 6.76 | 7.32 |
| **12%** | 4.87 | 5.12 | 5.41 | 5.75 | 6.16 |
| **13%** | 4.30 | 4.49 | 4.72 | 4.98 | 5.29 |

---

## Comparable Valuation

| Method | Multiple Range | Implied Value |
|--------|----------------|---------------|
| EV/EBITDA | 7-12x | NZ$4.60 - 8.70 |
| EV/Revenue | 2-3x | NZ$5.30 - 8.70 |
| P/E | 15-25x | NZ$4.20 - 7.00 |

---

## Key Risks

1. **Healthcare Worker Shortages** - NZ faces nursing shortages; competition with DHBs for talent
2. **Government Funding Risk** - Revenue partly dependent on government subsidies
3. **Key Personnel Risk** - Lean management team; loss of key executives could impact operations
4. **Competition** - Larger players (Ryman, Bupa, Summerset) operate in adjacent spaces
5. **Liquidity Risk** - Small cap with limited trading volume

---

## Conclusion

Third Age Health represents an attractive investment opportunity in the growing NZ aged care sector. The company benefits from structural demographic tailwinds, operates an asset-light business model with strong cash flow conversion, and has demonstrated consistent growth through both organic expansion and disciplined acquisitions.

Based on the DCF analysis, the stock appears undervalued at current levels, with an implied fair value of approximately **NZ$6.64** representing **38% upside** to the current share price of NZ$4.80.

**Investment Recommendation: Attractive at current levels**

---

*Disclaimer: This analysis is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence before making investment decisions.*
